Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer characterized by rapid tumor growth and early metastasis. Accurate prediction of prognosis and therapeutic response is crucial for optimizing treatment strategies…
Continue Reading
To address rural healthcare access disparities, the Advanced Research Projects Agency for Health office at the National Institutes of Health seeks to create a scalable vehicle platform that can provide advanced medical services outside…
Continue Reading
Explore AI’s evolution, challenges, and breakthroughs at RSNA23. Leaders, including Connie Lehman, MD, PhD, Etta D. Pisano, MD, and Fredrik Strand, MSc, MD, PhD, delve into clinical implementation challenges, cutting-edge research outcomes, and regulatory…
Continue Reading
A three-year collaboration integrates Lunit’s cutting-edge AI into Samsung’s premium X-ray devices, promising revolutionary enhancements in chest screening accuracy and speed. The partnership initially targets the US, Canada, and Europe, focusing on urgent medical…
Continue Reading
The collaborative LungIMPACT study which is gathering real-world evidence of AI-assisted diagnosis of lung cancer, is welcoming East Suffolk and North Essex NHS Foundation Trust.The study brings together UK academia and NHS trusts and…
Continue Reading
What You Should Know:
– Lunit, an innovator in AI-powered cancer diagnostics, and Samsung Electronics (Samsung Healthcare) have announced a groundbreaking three-year supply contract.
– The strategic partnership integrates Lunit’s cutting-edge AI technology into Samsung’s premium…
Continue Reading
CMS’s new national payment rate and unique reimbursement codes signal a transformative shift in radiotherapy reimbursement, removing barriers to the clinical adoption of RefleXion’s SCINTIX biology-guided radiotherapy. The breakthrough approach, utilizing emissions from cancer…
Continue Reading
Following a record 95 applications, judges have selected 25 digital health start-ups to advance to the next stage of Digital Health Rewired Pitchfest 2024.Some of the best start-ups from across the UK, Europe, US…
Continue Reading
Detroit-based Karmanos Cancer Institute, a network of 16 treatment locations across Michigan and Ohio that is part of McLaren Health Care, is using artificial intelligence to elevate risk assessment and is surfacing high-risk breast…
Continue Reading
Following a record 95 applications, our judges have chosen 25 digital health start-ups to advance to the next stage of Pitchfest 2024 competition. Some of the best start-ups from the UK, Europe, US and even as…
Continue Reading
